NEW YORK (GenomeWeb News) - Oxford Gene Technology has licensed patents covering its oligonucleotide array technology to NimbleGen, based in Madison, Wisc., the companies said today.
 
The companies have also signed a supply agreement under which OGT will have access to NimbleGen’s DNA microarrays for use in its services business. NimbleGen will also be able to make and sell OGT-designed arrays.
 
Financial terms of the agreements were not released.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.